文献速递胃肠外科急腹症与外科感染

小肠梗阻手术与非手术治疗:再入院率与死亡率比较

Should we let the sun set or rise on a small bowel obstruction: mortality and readmission rates in operative versus nonoperative management.
PubMed 文献 · Surg Endosc · 2025-09-12

基于美国国家再入院数据库2016-2017年的回顾性分析,纳入122,778例非计划入院的小肠梗阻成人患者,比较手术组(6.4%)与非手术组(93.6%)的再入院和死亡率。非手术组再入院风险高32%,再入院时死亡风险高50%;每次再入院使死亡风险增加4.0%。

要点

  • 非手术组再入院率29.9%高于手术组28.6%,调整后非手术组再入院风险高32%。
  • 再入院患者中非手术组死亡风险高50%,每次再入院死亡风险增加4.0%。
  • 非手术组再入院者88.3%为急诊再入院,其中10.6%需手术干预。

核心结论

  • 非手术管理小肠梗阻与更高的再入院率相关,且再入院时死亡率更高。
  • 每次再入院使死亡风险增加4.0%。

研究设计与样本

  • 回顾性分析美国国家再入院数据库2016-2017年数据。
  • 纳入122,778例年龄≥18岁因小肠梗阻非计划入院的患者。
  • 按索引住院期间是否手术分为手术组(6.4%)和非手术组(93.6%)。

主要发现

  • 总体再入院率29.8%,其中34.4%在30天内再入院。
  • 手术组再入院率28.6%,非手术组29.9%(p < 0.001)。
  • 调整分析显示非手术组再入院风险高32%(p < 0.001)。
  • 再入院患者中非手术组死亡风险高50%。
  • 每次再入院使死亡风险增加4.0%(p < 0.001)。

关键数值与推荐

  • 非手术组再入院者中88.3%为急诊再入院,10.6%需手术干预。
  • 增加再入院风险的其它因素包括女性、高Charlson合并症指数和入院诊断癌症。
  • 首次再入院时接受手术治疗与年轻、私人保险及索引住院期间非手术管理相关。

临床怎么用

  • 对小肠梗阻非手术管理的患者应加强再入院风险意识与随访。
  • 再入院本身增加死亡风险,需重视每次再入院的评估与干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recurrent small bowel obstruction (SBO) can result in significant morbidity and mortality. In this study, we aimed to compare readmission and its impact on operatively and nonoperatively managed patients admitted with SBO. METHODS: We performed a retrospective analysis using the National Readmission Database 2016-2017 and included all patients (≥ 18y) who were non-elective admissions for SBO during the index hospitalization. Patients were dichotomized into two groups: Operative group (OM) and nonoperative group (NOM). Primary outcomes included rates of readmission and mortality upon readmission. Secondary outcomes included complications, which were defined as fistula, abscess, perforation, peritonitis, and sepsis. RESULTS: 122,778 patients admitted for SBO were included. Overall, the readmission was 29.8%, with 34.4% readmitted within 30 days. 6.4% were OM, while 93.6% were NOM during index admission. Among OM patients, the readmission rate was significantly lower at 28.6% compared to NOM at 29.9% (p < 0.001). Among the readmitted NOM patients, 88.3% had emergency readmissions, with 10.6% requiring operative intervention. Adjusted analyses revealed that NOM had 32% higher odds of readmission (p < 0.001). Other factors increasing the odds of readmission included female sex, a high Charlson comorbidity index, and an admission diagnosis of cancer. Among readmitted patients, NOM had 50% higher odds of mortality during readmission. Each readmission raised the odds of mortality by 4.0% (p < 0.001). Operative management in the first readmission was associated with younger age, private insurance status, and non-operative management during the index admission. CONCLUSION: While cost, length of stay, and complications were higher in OM, NOM was associated with a higher readmission rate and mortality upon readmission. Each additional readmission for small bowel obstruction increased the odds of mortality by 4.0%.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Jose AM, Kirsch J, Prabhakaran K, et al. Should we let the sun set or rise on a small bowel obstruction: mortality and readmission rates in operative versus nonoperative management. Surg Endosc. 2025. PMID: 40938369. doi:10.1007/s00464-025-12059-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。